Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESALT: Diet and Diuretics for Severe Sleep Apnea
NCT01945801Phase 4Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Oct 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of furosemide + spironolactone in obstructive sleep apnea (OSA) (3 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Apnea-Hypopnea Index at 1 week. Started Oct 2013; status: completed.
02
Drugs
furosemide + spironolactone
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT01945801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01945801.